stockrowEnvista Holdings Corporation
NVST Healthcare Medical Instruments & Supplies
Envista Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 8.32% from fiscal 2024.
- Revenue
- +3.22%
- EPS
- +1,855.6%
- Free cash flow
- −6.48%
- Total debt
- −1.13%
Quarter to September 2026, against a year earlier
Follow NVST
Alert me
Envista Holdings Corporation (NVST) Revenue
Envista Holdings Corporation's revenue for fiscal 2025 was $2.7B, up 8.32% from $2.5B in fiscal 2024. Over the twelve months to 30 September 2026 it was $2.9B. Over the past ten years it has ranged from $1.9B (fiscal 2020) to $2.8B (fiscal 2018); the current reading is higher than 70% of that period. Envista Holdings Corporation ranks 16th of 47 Medical Instruments & Supplies companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2025 | $2.7B | 8.32% |
| FY2024 | $2.5B | (2.18%) |
| FY2023 | $2.6B | (0.10%) |
| FY2022 | $2.6B | 2.40% |
| FY2021 | $2.5B | 30.06% |
| FY2020 | $1.9B | (15.57%) |
| FY2019 | $2.3B | (19.68%) |
| FY2018 | $2.8B | 1.20% |
| FY2017 | $2.8B | 0.93% |
| FY2016 | $2.8B | — |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $691.5M | (5.34%) |
| Jun 2026 | $730.5M | 3.54% |
| Mar 2026 | $705.5M | (6.01%) |
| Dec 2025 | $750.6M | 12.05% |
| 28 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| MMED MiniMed Group, Inc. compare | $3.0B |
| NVST Envista Holdings Corporation | $2.9B |
| TFX Teleflex Incorporated compare | $2.3B |
| ICUI ICU Medical, Inc. compare | $2.2B |
| MMSI Merit Medical Systems, Inc. compare | $1.6B |
| STVN Stevanato Group S.p.A. compare | $1.4B |
| WRBY Warby Parker Inc. compare | $934.7M |
| ATRC AtriCure, Inc. compare | $589.8M |
| PLSE Pulse Biosciences, Inc compare | $1.5M |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on NVST
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement